Cancer-treatment drug Nexavar will soon be available at Rs. 8,880 per pack of 120 tablets. Bayer, a German multi-national, holds the patent for Nexavar (the brand name of sorafenib tosylate), which now sells at Rs.2.84 lakh.
The way for such a huge reduction in the price is cleared with India invoking a World Trade Organisation (WTO) provision and permitting the Hyderabad-based Natco Pharma to make sorafenib tosylate, which is used to treat kidney and liver cancer.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/rs284-lakh-cancer-drug-will-soon-cost-just-rs-8880
[2] http://admin.indiaenvironmentportal.org.in/category/author/ramnath-subbu
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/hindu-new-delhi
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/cancer
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/wto
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
